Navigation Links
Treating safety research like other clinical studies slows progress
Date:5/13/2008

Progress in patient safety research could slow to a crawl unless regulators work out a host of ethical issues, Johns Hopkins researchers assert in an upcoming opinion piece.

We cant apply a clinical paradigm to patient safety research. It just isnt the right fit, says Nancy Kass, Sc.D., deputy director for public health at the Johns Hopkins Berman Institute of Bioethics and an author of the article.

The piece, published in the June issue of The Joint Commission Journal on Quality and Patient Safety, was sparked by a 2006 study led by Peter Pronovost, M.D., Ph.D., professor of anesthesiology, critical care medicine, and surgery at the Johns Hopkins University School of Medicine. In the study, Pronovost, an expert on patient safety, implemented a checklist in intensive care units (ICUs) at 67 Michigan hospitals aimed at preventing bloodstream infections whenever doctors insert catheters.

The results were markedly positive: Bloodstream infections from catheters fell by two-thirds, and on average, infection rates in the ICUs went from 4 percent to zero. Over the course of the study, the program saved more than 1,500 lives and nearly $200 million.

Shortly after the studys results were published, however, an anonymous complaint led to a federal reexamination of the ethical oversight of the study. As in most human research, Pronovosts study had been reviewed by an institutional review board (IRB)an internal group required at most research institutions to use federal regulations to make sure research studies protect the welfare of human subjects.

Because Pronovosts study enforced safety measures already known to be effective, and because no data were ever collected from patients by name, the Johns Hopkins IRB classified Pronovosts study as exempt from further IRB review. This designation meant that informed consent was not necessary from the ICU patients and that IRB review from each of the 67 Michigan hospitals that part
'/>"/>

Contact: Christen Brownlee
cbrownlee@jhmi.edu
410-955-7832
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
3. Treating diabetes during pregnancy can break link to childhood obesity
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Treating depression may improve recovery of heart rate variability following coronary syndromes
8. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Stem cells show promise for treating Huntingtons disease
11. Treating obstructive sleep apnea, preventing heart attacks and strokes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... California (PRWEB) May 23, 2013 According ... titled “SBU-Led Study Reveals Nanoparticles Found in Everyday Items ... found in everyday items such as cosmetics and other ... human body. As a result, men and women who ... means that they develop wrinkles earlier than ...
(Date:5/23/2013)... Wei Angela Liu, MD, of Mamaroneck, NY, ... as Medical Director of Physical Medicine and ... rehabilitation care to patients of all ages and stages ... in biochemistry at Columbia College, honored as a Fu ... medical degree at New York University School of Medicine ...
(Date:5/23/2013)... Diversity Focus announced today that in 2013 ... of diversity. The results come from the 2013 Creative ... of this year. 1198 qualified residents took part. The ... its benchmark survey in 2008. , In both 2008 ... of diversity were race and ethnicity. But the numbers ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Mild to moderate ... impact on children,s brain development, British researchers report. ... expectant mother,s diet appear to put her child at ... preteen years, the study authors found. Pregnant women can ... and seafood, the researchers suggested. The finding, published ...
(Date:5/23/2013)... By Steven Reinberg HealthDay Reporter , , THURSDAY, ... frequent heartburn may be at increased risk for cancers ... don,t smoke or drink alcohol, a new study says. ... these cancers while prescription medications such as Prilosec, Nexium ... been a controversy about whether heartburn contributes to cancers ...
Breaking Medicine News(10 mins):Health News:Aging and Wrinkles – Gold Found in Everyday Products Can Accelerate the Visual Signs of Aging 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Diversity Focus Announces Results from the 2013 Creative Corridor Community Survey 2Health News:Low Prenatal Iodine May Affect Child's Brain Development 2Health News:Chronic Heartburn May Raise Odds for Throat Cancer: Study 2
... U.S.,Presidential candidate Hillary Clinton today pledged to expand the ... if elected, setting,the goal of ending malaria-related deaths in ... said this funding would be in addition to U.S.,government ... the Global,Fund to Fight AIDS, Tuberculosis, and Malaria, which ...
... Sumitomo Corporation of America,(SCOA) announced the appointment of ... animal healthcare company, Summit VetPharm, LLC. Mr.,Isohata joins ... 15,years as head of Sumitomo,s Household Insecticides and ... for the Petcare business,in the Life Science Division, ...
... their odds for cardiovascular disease , THURSDAY, Nov. ... cholesterol boosts their heart risks helps them stick ... at McGill University in Montreal enrolled more than ... problems who were instructed to change their lifestyle ...
... 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, ... called apoptosis plays a key role in development, and ... their work. As apoptotic cells degrade, they display standard ... fragmentation. , Now, Harvard Medical School researchers have uncovered ...
... million men and women in the United States live ... that permeates muscles in the neck, back and shoulders. ... understood, but research studies indicate that a new imaging ... definitive diagnosis and, perhaps eventually, new treatments for people ...
... adrenal masses are found incidentally during a CT scan, ... additional imaging follow-up, according to a recent study conducted ... , With increased utilization of CT, we are ... the patients were scanned, the so called incidentalomas, of ...
Cached Medicine News:Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 2Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 3Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 2Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 3Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 4Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 5Health News:Knowing Heart Risk Keeps Patients on Cholesterol Drugs 2Health News:Homeless cells find temporary lodging -- and their demise 2Health News:Homeless cells find temporary lodging -- and their demise 3Health News:MRE could provide a definitive diagnosis for people with muscle pain, Mayo Clinic study shows 2
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... May 22, 2013  The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®.  The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...
... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance).  The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...
Cached Medicine Technology:The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 2New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 3New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 4New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 5New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 7New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 8New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 9New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 10
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Inquire...
... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
... PRISM 7000 Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... accumulated PCR product is made possible ... and application-specific software in a single ...
Medicine Products: